1. Home
  2. SANA vs NMFC Comparison

SANA vs NMFC Comparison

Compare SANA & NMFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SANA
  • NMFC
  • Stock Information
  • Founded
  • SANA 2018
  • NMFC 2010
  • Country
  • SANA United States
  • NMFC United States
  • Employees
  • SANA N/A
  • NMFC N/A
  • Industry
  • SANA Medicinal Chemicals and Botanical Products
  • NMFC Finance/Investors Services
  • Sector
  • SANA Health Care
  • NMFC Finance
  • Exchange
  • SANA Nasdaq
  • NMFC Nasdaq
  • Market Cap
  • SANA 983.4M
  • NMFC 983.8M
  • IPO Year
  • SANA 2021
  • NMFC 2011
  • Fundamental
  • Price
  • SANA $4.90
  • NMFC $9.64
  • Analyst Decision
  • SANA Strong Buy
  • NMFC Hold
  • Analyst Count
  • SANA 6
  • NMFC 3
  • Target Price
  • SANA $8.00
  • NMFC $10.33
  • AVG Volume (30 Days)
  • SANA 6.7M
  • NMFC 768.1K
  • Earning Date
  • SANA 11-11-2025
  • NMFC 11-03-2025
  • Dividend Yield
  • SANA N/A
  • NMFC 13.26%
  • EPS Growth
  • SANA N/A
  • NMFC N/A
  • EPS
  • SANA N/A
  • NMFC 0.77
  • Revenue
  • SANA N/A
  • NMFC $355,675,000.00
  • Revenue This Year
  • SANA N/A
  • NMFC N/A
  • Revenue Next Year
  • SANA N/A
  • NMFC N/A
  • P/E Ratio
  • SANA N/A
  • NMFC $12.57
  • Revenue Growth
  • SANA N/A
  • NMFC N/A
  • 52 Week Low
  • SANA $1.26
  • NMFC $8.84
  • 52 Week High
  • SANA $7.30
  • NMFC $12.05
  • Technical
  • Relative Strength Index (RSI)
  • SANA 59.91
  • NMFC 52.74
  • Support Level
  • SANA $5.12
  • NMFC $9.17
  • Resistance Level
  • SANA $5.90
  • NMFC $9.82
  • Average True Range (ATR)
  • SANA 0.56
  • NMFC 0.19
  • MACD
  • SANA -0.02
  • NMFC 0.07
  • Stochastic Oscillator
  • SANA 49.89
  • NMFC 80.59

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

About NMFC New Mountain Finance Corporation

New Mountain Finance Corp is a closed-end, non-diversified management investment company. It invests in equity interests such as preferred stock, common stock, warrants, or options received in connection with debt investments or may include direct investment in the equity of private companies. The company's investment objective is to generate current income and capital appreciation through sourcing and origination of debt securities at all levels of the capital structure, including first and second-lien debt, notes, bonds and mezzanine securities.

Share on Social Networks: